{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,11,11]],"date-time":"2025-11-11T15:45:39Z","timestamp":1762875939042},"reference-count":43,"publisher":"Impact Journals, LLC","issue":"3","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Oncotarget"],"published-print":{"date-parts":[[2018,1,9]]},"DOI":"10.18632\/oncotarget.23261","type":"journal-article","created":{"date-parts":[[2017,12,15]],"date-time":"2017-12-15T13:29:18Z","timestamp":1513344558000},"page":"3353-3364","source":"Crossref","is-referenced-by-count":5,"title":["Del17p does not always significantly influence the survival of B-cell chronic lymphoproliferative disorders"],"prefix":"10.18632","volume":"9","author":[{"given":"Shuhua","family":"Yi","sequence":"first","affiliation":[{"name":"State Key Laboratory of Experimental Hematology, Institute of Hematology and Blood Disease Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Tianjin, P.R.China"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Zengjun","family":"Li","sequence":"additional","affiliation":[{"name":"State Key Laboratory of Experimental Hematology, Institute of Hematology and Blood Disease Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Tianjin, P.R.China"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Dehui","family":"Zou","sequence":"additional","affiliation":[{"name":"State Key Laboratory of Experimental Hematology, Institute of Hematology and Blood Disease Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Tianjin, P.R.China"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Wenjie","family":"Xiong","sequence":"additional","affiliation":[{"name":"State Key Laboratory of Experimental Hematology, Institute of Hematology and Blood Disease Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Tianjin, P.R.China"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Heng","family":"Li","sequence":"additional","affiliation":[{"name":"State Key Laboratory of Experimental Hematology, Institute of Hematology and Blood Disease Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Tianjin, P.R.China"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Rui","family":"Cui","sequence":"additional","affiliation":[{"name":"State Key Laboratory of Experimental Hematology, Institute of Hematology and Blood Disease Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Tianjin, P.R.China"},{"name":"Department of Hematology, Tianjin First Center Hospital, Tianjin, P.R.China"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Chengwen","family":"Li","sequence":"additional","affiliation":[{"name":"State Key Laboratory of Experimental Hematology, Institute of Hematology and Blood Disease Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Tianjin, P.R.China"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yuting","family":"Yan","sequence":"additional","affiliation":[{"name":"State Key Laboratory of Experimental Hematology, Institute of Hematology and Blood Disease Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Tianjin, P.R.China"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Wei","family":"Liu","sequence":"additional","affiliation":[{"name":"State Key Laboratory of Experimental Hematology, Institute of Hematology and Blood Disease Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Tianjin, P.R.China"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Rui","family":"Lv","sequence":"additional","affiliation":[{"name":"State Key Laboratory of Experimental Hematology, Institute of Hematology and Blood Disease Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Tianjin, P.R.China"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Zhen","family":"Yu","sequence":"additional","affiliation":[{"name":"State Key Laboratory of Experimental Hematology, Institute of Hematology and Blood Disease Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Tianjin, P.R.China"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Weiwei","family":"Chen","sequence":"additional","affiliation":[{"name":"State Key Laboratory of Experimental Hematology, Institute of Hematology and Blood Disease Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Tianjin, P.R.China"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yan","family":"Xu","sequence":"additional","affiliation":[{"name":"State Key Laboratory of Experimental Hematology, Institute of Hematology and Blood Disease Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Tianjin, P.R.China"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Gang","family":"An","sequence":"additional","affiliation":[{"name":"State Key Laboratory of Experimental Hematology, Institute of Hematology and Blood Disease Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Tianjin, P.R.China"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Huijun","family":"Wang","sequence":"additional","affiliation":[{"name":"State Key Laboratory of Experimental Hematology, Institute of Hematology and Blood Disease Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Tianjin, P.R.China"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kun","family":"Ru","sequence":"additional","affiliation":[{"name":"State Key Laboratory of Experimental Hematology, Institute of Hematology and Blood Disease Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Tianjin, P.R.China"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tao","family":"Cheng","sequence":"additional","affiliation":[{"name":"State Key Laboratory of Experimental Hematology, Institute of Hematology and Blood Disease Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Tianjin, P.R.China"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jianxiang","family":"Wang","sequence":"additional","affiliation":[{"name":"State Key Laboratory of Experimental Hematology, Institute of Hematology and Blood Disease Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Tianjin, P.R.China"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lugui","family":"Qiu","sequence":"additional","affiliation":[{"name":"State Key Laboratory of Experimental Hematology, Institute of Hematology and Blood Disease Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Tianjin, P.R.China"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"7892","published-online":{"date-parts":[[2017,12,15]]},"reference":[{"key":"1","first-page":"194","volume-title":"World Health Organization Classification of Tumours of Haematopoietic and Lymphoid Tissue","author":"Vardiman","year":"2008","edition":"4th edn"},{"key":"2","doi-asserted-by":"publisher","first-page":"776","DOI":"10.4065\/83.7.776S0025-6196(11)60916-6","article-title":"Predictive value of blood and bone marrow flow cytometry in B-cell lymphoma classification: comparative analysis of flow cytometry and tissue biopsy in 252 patients","volume":"83","author":"Hanson","year":"2008","journal-title":"Mayo Clin Proc"},{"key":"3","doi-asserted-by":"crossref","first-page":"1910","DOI":"10.1056\/NEJM200012283432602","article-title":"Genomic aberrations and survival in chronic lymphocytic leukemia","volume":"343","author":"Lichter","year":"2000","journal-title":"N Engl J Med"},{"key":"4","doi-asserted-by":"publisher","first-page":"2442","DOI":"10.1038\/sj.leu.2404935","article-title":"Comprehensive genetic characterization of CLL: a study on 506 cases analysed with chromosome banding analysis, interphase FISH, IgV(H) status and immunophenotyping","volume":"21","author":"Haferlach","year":"2007","journal-title":"Leukemia"},{"key":"5","doi-asserted-by":"publisher","first-page":"1164","DOI":"10.1016\/S0140-6736(10)61381-5","article-title":"Addition of rituximab to fludarabine and cyclophosphamide in patients with chronic lymphocytic leukaemia: a randomised, open-label, phase 3 trial","volume":"376","author":"Zinzani","year":"2010","journal-title":"Lancet"},{"key":"6","doi-asserted-by":"crossref","first-page":"747","DOI":"10.1038\/sj.leu.2400635","article-title":"Characteristic pattern of chromosomal gains and losses in marginal zone B cell lymphoma detected by comparative genomic hybridization","volume":"11","author":"Raap","year":"1997","journal-title":"Leukemia"},{"key":"7","doi-asserted-by":"publisher","first-page":"1479","DOI":"10.1182\/blood-2010-02-267476","article-title":"Cytogenetic aberrations and their prognostic value in a series of 330 splenic marginal zone B-cell lymphomas: a multicenter study of the Splenic B-Cell Lymphoma Group","volume":"116","author":"Davis","year":"2010","journal-title":"Blood"},{"key":"8","doi-asserted-by":"publisher","first-page":"150","DOI":"10.1016\/j.cancergencyto.2006.04.009","article-title":"6q deletion discriminates Waldenstrom macroglobulinemia from IgM monoclonal gammopathy of undetermined significance","volume":"169","author":"Fonseca","year":"2006","journal-title":"Cancer Genet Cytogenet"},{"key":"9","doi-asserted-by":"crossref","first-page":"4523","DOI":"10.1200\/JCO.2002.12.006","article-title":"Clinicopathologic correlations of genomic gains and losses in follicular lymphoma","volume":"20","author":"Bentz","year":"2002","journal-title":"J Clin Oncol"},{"key":"10","doi-asserted-by":"publisher","first-page":"195","DOI":"10.1002\/gcc.10314","article-title":"Identification of cytogenetic subgroups and karyotypic pathways of clonal evolution in follicular lymphomas","volume":"39","author":"Horsman","year":"2004","journal-title":"Genes Chromosomes Cancer"},{"key":"11","doi-asserted-by":"publisher","first-page":"137","DOI":"10.1182\/blood-2008-02-140616","article-title":"Genome-wide profiling of follicular lymphoma by array comparative genomic hybridization reveals prognostically significant DNA copy number imbalances","volume":"113","author":"Gascoyne","year":"2009","journal-title":"Blood"},{"key":"12","doi-asserted-by":"publisher","first-page":"S82","DOI":"10.1016\/j.bbmt.2011.11.012","article-title":"Follicular lymphoma: prognostic factors, conventional therapies, and hematopoietic cell transplantation","volume":"18","author":"Laport","year":"2012","journal-title":"Biol Blood Marrow Transplant"},{"key":"13","doi-asserted-by":"publisher","first-page":"80","DOI":"10.1111\/j.1365-2141.2006.06389.x","article-title":"6q deletion in Waldenstrom macroglobulinemia is associated with features of adverse prognosis","volume":"136","author":"Dispenzieri","year":"2007","journal-title":"Br J Haematol"},{"key":"14","doi-asserted-by":"publisher","first-page":"649","DOI":"10.3324\/haematol.2012.070458","article-title":"Chromosomal aberrations and their prognostic value in a series of 174 untreated patients with Waldenstrom\u2019s macroglobulinemia","volume":"98","author":"Andrieux","year":"2013","journal-title":"Haematologica"},{"key":"15","doi-asserted-by":"publisher","first-page":"461","DOI":"10.1002\/path.2665","article-title":"Splenic marginal zone lymphoma: characterization of 7q deletion and its value in diagnosis","volume":"220","author":"de Leval","year":"2010","journal-title":"J Pathol"},{"key":"16","doi-asserted-by":"crossref","first-page":"1410","DOI":"10.1182\/blood.V100.4.1410.h81602001410_1410_1416","article-title":"V(H) mutation status, CD38 expression level, genomic aberrations, and survival in chronic lymphocytic leukemia","volume":"100","author":"Stilgenbauer","year":"2002","journal-title":"Blood"},{"key":"17","doi-asserted-by":"publisher","first-page":"42362","DOI":"10.18632\/oncotarget.5705","article-title":"High incidence of MYC and BCL2 abnormalities in mantle cell lymphoma, although only MYC abnormality predicts poor survival","volume":"6","author":"Xu","year":"2015","journal-title":"Oncotarget"},{"key":"18","doi-asserted-by":"publisher","first-page":"2148","DOI":"10.1158\/1078-0432.CCR-14-25761078-0432.CCR-14-2576","article-title":"The impact of clone size on the prognostic value of chromosome aberrations by fluorescencehybridization in multiple myeloma","volume":"21","author":"Zang","year":"2015","journal-title":"Clin Cancer Res"},{"key":"19","doi-asserted-by":"publisher","first-page":"230","DOI":"10.1016\/S0140-6736(07)61125-8","article-title":"Assessment of fludarabine plus cyclophosphamide for patients with chronic lymphocytic leukaemia (the LRF CLL4 Trial): a randomised controlled trial","volume":"370","author":"Smith","year":"2007","journal-title":"Lancet"},{"key":"20","doi-asserted-by":"publisher","first-page":"1595","DOI":"10.1182\/blood-2010-01-264275","article-title":"Genome-wide DNA profiling of marginal zone lymphomas identifies subtype-specific lesions with an impact on the clinical outcome","volume":"117","author":"Govi","year":"2011","journal-title":"Blood"},{"key":"21","doi-asserted-by":"publisher","first-page":"481","DOI":"10.1182\/asheducation-2010.1.481","article-title":"Understanding and managing ultra high-risk chronic lymphocytic leukemia","volume":"2010","author":"Zenz","year":"2010","journal-title":"Hematology Am Soc Hematol Educ Program"},{"key":"22","doi-asserted-by":"publisher","first-page":"957","DOI":"10.1182\/blood-2009-03-210591","article-title":"De novo deletion 17p13.1 chronic lymphocytic leukemia shows significant clinical heterogeneity: the M. D. Anderson and Mayo Clinic experience","volume":"114","author":"Keating","year":"2009","journal-title":"Blood"},{"key":"23","doi-asserted-by":"publisher","first-page":"117","DOI":"10.1111\/j.1365-2141.2007.06526.x","article-title":"Cytogenetic abnormalities additional to t(11;14) correlate with clinical features in leukaemic presentation of mantle cell lymphoma, and may influence prognosis: a study of 60 cases by FISH","volume":"137","author":"Catovsky","year":"2007","journal-title":"Br J Haematol"},{"key":"24","doi-asserted-by":"publisher","first-page":"439","DOI":"10.1002\/gcc.20754","article-title":"Incidence and prognostic impact of secondary cytogenetic aberrations in a series of 145 patients with mantle cell lymphoma","volume":"49","author":"Siebert","year":"2010","journal-title":"Genes Chromosomes Cancer"},{"key":"25","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1016\/S0165-4608(01)00526-X","article-title":"Deletions of 17p13.1 and 13q14 are uncommon in Waldenstrom macroglobulinemia clonal cells and mostly seen at the time of disease progression","volume":"132","author":"Witzig","year":"2002","journal-title":"Cancer Genet Cytogenet"},{"key":"26","doi-asserted-by":"publisher","first-page":"1160","DOI":"10.1038\/sj.leu.24033692403369","article-title":"Analysis of IgH translocations, chromosome 13q14 and 17p13.1(p53) deletions by fluorescencehybridization in Waldenstrom's macroglobulinemia: a single center study of 22 cases","volume":"18","author":"Stewart","year":"2004","journal-title":"Leukemia"},{"key":"27","doi-asserted-by":"publisher","first-page":"42362","DOI":"10.18632\/oncotarget.57055705","article-title":"High incidence of MYC and BCL2 abnormalities in mantle cell lymphoma, although only MYC abnormality predicts poor survival","volume":"6","author":"Xu","year":"2015","journal-title":"Oncotarget"},{"key":"28","doi-asserted-by":"publisher","first-page":"1012","DOI":"10.1158\/0008-5472.CAN-07-3105","article-title":"Integrated genomic profiling of chronic lymphocytic leukemia identifies subtypes of deletion 13q14","volume":"68","author":"Malek","year":"2008","journal-title":"Cancer Res"},{"key":"29","doi-asserted-by":"publisher","first-page":"651","DOI":"10.1038\/modpathol.2011.213","article-title":"Genomic analysis of marginal zone and lymphoplasmacytic lymphomas identified common and disease-specific abnormalities","volume":"25","author":"Fonseca","year":"2012","journal-title":"Mod Pathol"},{"key":"30","doi-asserted-by":"publisher","first-page":"139","DOI":"10.1002\/cyto.b.20390","article-title":"Impact of trisomy 12, del(13q), del(17p), and del(11q) on the immunophenotype, DNA ploidy status, and proliferative rate of leukemic B-cells in chronic lymphocytic leukemia","volume":"74","author":"Orfao","year":"2008","journal-title":"Cytometry B Clin Cytom"},{"key":"31","doi-asserted-by":"publisher","first-page":"709","DOI":"10.1111\/j.1365-2141.2008.07248.x","article-title":"Richter syndrome: a review of clinical, ocular, neurological and other manifestations","volume":"142","author":"Omoti","year":"2008","journal-title":"Br J Haematol"},{"key":"32","doi-asserted-by":"publisher","first-page":"1038","DOI":"10.1002\/gcc.20606","article-title":"Prognostic significance of secondary cytogenetic alterations in follicular lymphomas","volume":"47","author":"Horsman","year":"2008","journal-title":"Genes Chromosomes Cancer"},{"key":"33","first-page":"1640","article-title":"The immunological profile of B-cell disorders and proposal of a scoring system for the diagnosis of CLL","volume":"8","author":"Catovsky","year":"1994","journal-title":"Leukemia"},{"key":"34","doi-asserted-by":"publisher","first-page":"2088","DOI":"10.1080\/10428190600727939","article-title":"Deciphering leukemic B-cell chronic lymphoproliferative disorders","volume":"47","author":"Levy","year":"2006","journal-title":"Leuk Lymphoma"},{"key":"35","doi-asserted-by":"publisher","first-page":"349","DOI":"10.1002\/ajh.21065","article-title":"A multicenter retrospective clinical study of CD5\/CD10-negative chronic B cell leukemias","volume":"83","author":"Lambertenghi Deliliers","year":"2008","journal-title":"Am J Hematol"},{"key":"36","doi-asserted-by":"publisher","first-page":"655","DOI":"10.1309\/7Q1J-1AA8-DU4Q-PVLQ","article-title":"Typical and atypical chronic lymphocytic leukemia differ clinically and immunophenotypically","volume":"116","author":"Hsi","year":"2001","journal-title":"Am J Clin Pathol"},{"key":"37","doi-asserted-by":"publisher","first-page":"459","DOI":"10.1111\/ijlh.12167","article-title":"Morphologic identification of atypical chronic lymphocytic leukemia by digital microscopy","volume":"36","author":"Keohane","year":"2014","journal-title":"Int J Lab Hematol"},{"key":"38","doi-asserted-by":"publisher","first-page":"1235","DOI":"10.1016\/j.leukres.2010.03.020","article-title":"CD5+ B-cell lymphoproliferative disorders: Beyond chronic lymphocytic leukemia and mantle cell lymphoma","volume":"34","author":"Hanson","year":"2010","journal-title":"Leuk Res"},{"key":"39","first-page":"132","volume-title":"Pathology and Genetics of Tumours of Hematopoietic and Lymphoid Tissue. World Health Organization Classification of Tumours","author":"JW V","year":"2001"},{"key":"40","doi-asserted-by":"publisher","first-page":"5446","DOI":"10.1182\/blood-2007-06-093906","article-title":"Guidelines for the diagnosis and treatment of chronic lymphocytic leukemia: a report from the International Workshop on Chronic Lymphocytic Leukemia updating the National Cancer Institute-Working Group 1996 guidelines","volume":"111","author":"Kipps","year":"2008","journal-title":"Blood"},{"key":"41","doi-asserted-by":"crossref","first-page":"2332","DOI":"10.1200\/JCO.1998.16.7.2332","article-title":"Doxorubicin-containing regimen with or without interferon alfa-2b for advanced follicular lymphomas: final analysis of survival and toxicity in the Groupe d\u2019Etude des Lymphomes Folliculaires 86 Trial","volume":"16","author":"Coiffier","year":"1998","journal-title":"J Clin Oncol"},{"key":"42","doi-asserted-by":"publisher","first-page":"1404","DOI":"10.1182\/blood-2014-03-565135","article-title":"Treatment recommendations for patients with Waldenstrom macroglobulinemia (WM) and related disorders: IWWM-7 consensus","volume":"124","author":"Morel","year":"2014","journal-title":"Blood"},{"key":"43","doi-asserted-by":"publisher","first-page":"353","DOI":"10.3324\/haematol.2013.088211","article-title":"Chromosome 1q21 gains confer inferior outcomes in multiple myeloma treated with bortezomib but copy number variation and percentage of plasma cells involved have no additional prognostic value","volume":"99","author":"Qiu","year":"2014","journal-title":"Haematologica"}],"container-title":["Oncotarget"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.oncotarget.com\/lookup\/doi\/10.18632\/oncotarget.23261","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,5,9]],"date-time":"2020-05-09T10:59:25Z","timestamp":1589021965000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.oncotarget.com\/lookup\/doi\/10.18632\/oncotarget.23261"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,12,15]]},"references-count":43,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2018,1,9]]}},"alternative-id":["23261","29423051"],"URL":"https:\/\/doi.org\/10.18632\/oncotarget.23261","relation":{},"ISSN":["1949-2553"],"issn-type":[{"value":"1949-2553","type":"electronic"}],"subject":[],"published":{"date-parts":[[2017,12,15]]}}}